MIM Software Inc. Announces FDA Clearance of Contour ProtégéAI+
Zero-Click Contouring: Automatic OAR and LNL Contouring for Dosimetrists and PhysiciansCLEVELAND, OH / ACCESSWIRE / December 5, 2023 / MIM...
Day: December 5, 2023
MIM Software Inc. Announces FDA Clearance of Contour ProtégéAI+
Zero-Click Contouring: Automatic OAR and LNL Contouring for Dosimetrists and PhysiciansCLEVELAND, OH / ACCESSWIRE / December 5, 2023 / MIM...
Dr. Marlene Grenon, MD, MBA, Joins CareSimple Board of Directors
Renowned Medical Innovator and Business Strategist, Dr. Marlene Grenon, Joins CareSimple's Board, Bringing a Wealth of Expertise in Digital Health...
Dr. Marlene Grenon, MD, MBA, Joins CareSimple Board of Directors
Renowned Medical Innovator and Business Strategist, Dr. Marlene Grenon, Joins CareSimple's Board, Bringing a Wealth of Expertise in Digital Health...
Nitinotes Surgical in Full Swing: Impressive Board Appointment, Over 90 Patients Treated, 400+ Sutures Performed, and a $10.1M Series B Funding Round Closure
Innovating a new era in endoscopic obesity treatment with Nitinotes' EndoZip™ System, a revolutionary, fully automated suturing device.CAESAREA, ISRAEL /...
Nitinotes Surgical in Full Swing: Impressive Board Appointment, Over 90 Patients Treated, 400+ Sutures Performed, and a $10.1M Series B Funding Round Closure
Innovating a new era in endoscopic obesity treatment with Nitinotes' EndoZip™ System, a revolutionary, fully automated suturing device.CAESAREA, ISRAEL /...
SpendMend Hires Bryan Olson as Western U.S. Area Vice President of Sales
Former Stryker Sales Leader Brings Decades of Expertise to Drive Platform Sales.GRAND RAPIDS, MI / ACCESSWIRE / December 5, 2023...
Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment
Tel Aviv, Israel / Vancouver, Canada, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY)...
Expert Panel Provides Updated Data for Epilepsy and Pregnancy
BOSTON, MA / ACCESSWIRE / December 5, 2023 / The Epilepsy & Pregnancy Medical Consortium (EPMC), an expert panel of...
3Win Corp. Executes Definitive Agreement to Acquire Serenus Global, Inc.
TEMPE, AZ / ACCESSWIRE / December 5, 2023 / 3Win Corp., a Tempe, Arizona-based global wholesale distributor of CCELL® vape...
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
STONY BROOK, NY / ACCESSWIRE / December 5, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),...
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today...
Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day
BRIDGEWATER, NJ / ACCESSWIRE / December 5, 2023 / Salix Pharmaceuticals, the gastroenterology division of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC),...
Biomea Fusion Announces Health Canada Clearance of Clinical Trial Application (CTA) for BMF-219 in Type 1 Diabetes
BMF-219 is a novel investigational covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes...
Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab with New U.S. Patent Issuance
Upcoming PDUFA goal date of January 3, 2024 U.S. patent protection for cosibelimab through at least May 2038 WALTHAM, Mass.,...
Cerevance to Participate in Fireside Chat at the 2023 RBC Capital Markets Healthcare Private Company Virtual Conference
BOSTON, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system...
Leading Pan-European Ferry and Logistics Company, P&O Ferries, Adopts Fingerprint Drug Screening Solution for On-Board, Random Testing of Seafaring Staff
Intelligent Fingerprinting Drug Screening System is expected to reduce P&O Ferries’ overall drug testing costs by 90% Easy-to-use, hygienic fingerprint sweat...
Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot
MAvERIC-Pilot is a Phase II Study in Recurrent Pericarditis and is Anticipated to Complete Patient Recruitment during Q1 2024Toronto, Ontario--(Newsfile...
Skye Bioscience and Tautomer Bioscience Enter Exclusive License for SBI-100 for Development and Sale of Products for Chronic Pain and Other Indications in South Africa and Rest of Africa
San Diego, California and Johannesburg, South Africa--(Newsfile Corp. - December 5, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a...
3Aware Integrates With Mayo Clinic Platform to Speed the Evolution of MedTech Compliance
INDIANAPOLIS, IN / ACCESSWIRE / December 5, 2023 / 3Aware, a pioneering force in the MedTech sector, is working with...